HK1118721A1 - Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops l- l- - Google Patents

Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops l- l-

Info

Publication number
HK1118721A1
HK1118721A1 HK08110830.5A HK08110830A HK1118721A1 HK 1118721 A1 HK1118721 A1 HK 1118721A1 HK 08110830 A HK08110830 A HK 08110830A HK 1118721 A1 HK1118721 A1 HK 1118721A1
Authority
HK
Hong Kong
Prior art keywords
carnitines
carnitine
alkanoyl
medicament
drops
Prior art date
Application number
HK08110830.5A
Other languages
English (en)
Chinese (zh)
Inventor
Aleardo Koverech
Nicola Pescosolido
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1118721A1 publication Critical patent/HK1118721A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK08110830.5A 2005-07-01 2008-09-29 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops l- l- HK1118721A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05014337 2005-07-01
PCT/EP2006/062919 WO2007003481A1 (fr) 2005-07-01 2006-06-06 Utilisation de l-carnitine ou de l-carnitines alcanoyle dans la preparation de medicament ou de complement physiologique pour usage ophthalmique sous forme de gouttes ophtalmiques

Publications (1)

Publication Number Publication Date
HK1118721A1 true HK1118721A1 (en) 2009-02-20

Family

ID=36930661

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08110830.5A HK1118721A1 (en) 2005-07-01 2008-09-29 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops l- l-

Country Status (12)

Country Link
US (2) US7655698B2 (fr)
EP (1) EP1906949B1 (fr)
JP (1) JP5117384B2 (fr)
KR (1) KR101401353B1 (fr)
CN (1) CN101242825B (fr)
AU (1) AU2006265248B2 (fr)
BR (1) BRPI0612596A2 (fr)
CA (1) CA2611909C (fr)
HK (1) HK1118721A1 (fr)
MX (1) MX2007016047A (fr)
TW (1) TWI404526B (fr)
WO (1) WO2007003481A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0612596A2 (pt) * 2005-07-01 2010-11-23 Sigma Tau Ind Farmaceuti uso de l-carnitina ou alcanoil-l-carnitinas para a preparação de um suplemento ou medicamento fisiológico para uso oftálmico na forma de gotas oftálmicas
CN101534812B (zh) * 2006-12-11 2012-09-05 希格马托制药工业公司 L-卡尼汀制备用于治疗角膜疾病的滴眼剂形式药物的用途
EP2101725A1 (fr) * 2006-12-14 2009-09-23 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Utilisation de l-carnitine ou de l-carnitines d'alcanoyle dans la préparation d'un supplément physioloqiue ou d'un médicament à usage ophtalmique sous la forme de gouttes pour les yeux
SG176525A1 (en) * 2006-12-22 2011-12-29 Sigma Tau Ind Farmaceuti Gel useful for the delivery of ophthalmic drugs
WO2009006130A2 (fr) * 2007-06-28 2009-01-08 Bausch & Lomb Incorporated Solution ophtalmique à base d'hyaluronate exempte de sel
TWI474817B (zh) * 2008-07-04 2015-03-01 Sigma Tau Ind Farmaceuti 用於預防或治療調節性眼疲勞之化合物類
WO2010085568A1 (fr) * 2009-01-21 2010-07-29 The Research Foundation Of State University Of New York Procédés de diagnostic et de traitement d'une kératoconjonctivite sèche grave
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
EP2363126A1 (fr) * 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition comprenant une L-carnitine en tant que principe actif en combinaison avec le glucoside de l'hydroxykynurénine, pour la prévention et/ou le traitement de pathologies de l'oeil dues au rayonnement ultraviolet
WO2013142912A1 (fr) * 2012-03-30 2013-10-03 Brien Holden Vision Institute Méthodes et compositions réduisant l'inconfort oculaire
US10238673B2 (en) * 2013-03-13 2019-03-26 Genetic Disease Investigators, LLC Methods and compositions for treatment of dry eye and correction of organ dysfunctions
EP2783695A1 (fr) * 2013-03-28 2014-10-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Supplément physioloqiue ou médicament à usage ophtalmique contenant de la L-carnitine ou des L-carnitines alcanoyles en combinaison avec eledoisin
US9173915B1 (en) 2014-10-10 2015-11-03 Peter F. Kador Antioxidant eye drops
CN110559261A (zh) * 2018-06-06 2019-12-13 常州药物研究所有限公司 含有纳米交联透明质酸的脂质体微乳及其制备方法和应用
CN110604811B (zh) * 2018-06-14 2023-01-31 陕西慧康生物科技有限责任公司 含有重组人溶菌酶和重组人表皮生长因子的人工泪液
CN110604812B (zh) * 2018-06-14 2023-01-31 陕西慧康生物科技有限责任公司 一种含有重组人溶菌酶的人工泪液
EP4125858A1 (fr) * 2020-04-28 2023-02-08 Lonza Consumer Health Inc. Composition nutritionnelle comprenant de la carnitine et méthode de traitement ou de prévention d'une infection chez un mammifère
WO2023069036A1 (fr) * 2021-10-18 2023-04-27 Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi Formulation ophtalmique pour le traitement et la prévention de la cataracte et son procédé de production

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1263606A (fr) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Preparations ophtalmiques non toxiques
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
IT1235153B (it) * 1988-11-15 1992-06-22 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
EP0546728A3 (en) * 1991-12-13 1993-09-08 Alcon Laboratories Inc Physiological tear compositions and methods for their preparation
WO1995005803A1 (fr) * 1993-08-20 1995-03-02 Alcon Laboratories, Inc. Excipients liquides ophtalmiques a usage local
AU3484895A (en) * 1994-09-14 1996-03-29 Taisho Pharmaceutical Co., Ltd. Eye drops for repairing corneal disturbance
JPH08133968A (ja) * 1994-09-14 1996-05-28 Taisho Pharmaceut Co Ltd 角膜障害修復用点眼液
CA2235626C (fr) * 1995-11-14 2002-01-01 Xoma Corporation Methode pour traiter des complications liees aux lesions de la cornee
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
US5817630A (en) * 1997-03-18 1998-10-06 Austin Nutriceutical Corporation Glutathione antioxidant eye drops
US6585987B1 (en) * 1998-11-13 2003-07-01 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
TR200302105T4 (tr) * 2000-04-07 2004-02-23 Laboratoire Medidom S. A. Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
RU2165749C1 (ru) * 2000-07-06 2001-04-27 Общество с ограниченной ответственностью "Научно-экспериментальное производство Микрохирургия глаза" Способ восстановления эндотелия роговицы
US6812251B2 (en) * 2001-03-15 2004-11-02 Rhode Island Hospital Taurine compounds
AU2003259145A1 (en) * 2002-07-17 2004-02-02 Spencer P. Thornton Treatment for dry eye syndrome
US7465463B2 (en) * 2002-09-04 2008-12-16 Polyheal, Ltd. Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
WO2004084877A1 (fr) * 2003-03-26 2004-10-07 Menicon Co., Ltd. Composition a usage ophtalmique
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
BRPI0612596A2 (pt) * 2005-07-01 2010-11-23 Sigma Tau Ind Farmaceuti uso de l-carnitina ou alcanoil-l-carnitinas para a preparação de um suplemento ou medicamento fisiológico para uso oftálmico na forma de gotas oftálmicas

Also Published As

Publication number Publication date
MX2007016047A (es) 2008-03-10
US20070265338A1 (en) 2007-11-15
TWI404526B (zh) 2013-08-11
BRPI0612596A2 (pt) 2010-11-23
EP1906949B1 (fr) 2015-02-11
EP1906949A1 (fr) 2008-04-09
US7655698B2 (en) 2010-02-02
CN101242825A (zh) 2008-08-13
CA2611909C (fr) 2014-01-07
CN101242825B (zh) 2011-03-30
JP5117384B2 (ja) 2013-01-16
CA2611909A1 (fr) 2007-01-11
US20100093858A1 (en) 2010-04-15
WO2007003481A1 (fr) 2007-01-11
US8377988B2 (en) 2013-02-19
JP2009500369A (ja) 2009-01-08
AU2006265248A1 (en) 2007-01-11
KR101401353B1 (ko) 2014-05-29
AU2006265248B2 (en) 2011-12-15
TW200744574A (en) 2007-12-16
KR20080030077A (ko) 2008-04-03

Similar Documents

Publication Publication Date Title
HK1118721A1 (en) Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops l- l-
USD647282S1 (en) Pajamas with detachable feet
USD638591S1 (en) Bone shape absorbent pad
PL1863387T3 (pl) Nieinwazyjne pomiary w ludzkim ciele
IL190284A (en) Use of milenzipran, or a suitable pharmaceutical salt, in the preparation of a drug for the treatment of fibromyalgia
IL183929A0 (en) Use of inerferon - ?? in the preparation of a medicament
GB2428974B (en) Further medical use of a botanical drug or dietary supplement
IL186555A (en) (4r, 9as) –5– Hydroxy – 4 – methyl – 6,10 – dioxo –10.9 a, 9,6,4,3 – hexahydro – 2 h – 1– oxa –8 a, 4a 4,2-diplooro-benzylamide carboxylic acid or its pharmacy salt, a preparation containing it and its use in the treatment or prevention of HIV
EP1758595A4 (fr) Utilisation de conjugues lipidiques dans le traitement de maladies
IL190150A0 (en) New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
IL195626A (en) Use of an ophthalmic device containing at least one prescription drug in combination with any carrier suitable for the provision of an eye for the preparation of a drug or an ophthalmic drug for the treatment of the disease in the back of the eye in a person or animal
IL186544A (en) Use of Acid 3,1 - Propandysulfonic or Sodium Salt in the Preparation of Pharmaceuticals for the Treatment of aa Amyloidosis and Pharmaceuticals for the Treatment of aa Amyloidosis
TWI366457B (en) Use of a beta2-adrenoceptor agonist for the preparation of a dermatological medicament
WO2007016679A3 (fr) Formes posologiques combinees a base de levodopa et de carbidopa a liberation immediate et a liberation controlee
HRP20130319T1 (hr) Upotreba kombinacije koju äśine l-karnitin ili alkanoil-l-karnitin, benzokinon topljiv u lipidima i omega-3-polinezasiä†ena masna kiselina, u pripravi dodatka za prehranu ili medikamenta za lijeäśenje bolesti rožnice
EP2094281A4 (fr) Utilisation de conjugués lipidiques dans le traitement de maladies ou de troubles oculaires
HUP0700370A2 (en) Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
ZA201007391B (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium in the blood
PL2918286T3 (pl) Preparat farmaceutyczny zawierający insulinę w postaci krystalicznej, jak również w formie rozpuszczonej
USD668972S1 (en) Milk bottle expiration timer
IL212214A0 (en) Use of lipid conjugates in the treatment of disease
HK1135019A1 (en) Use of l-carnitine for the preparation of a medicament in the form of eye- drops for treating corneal diseases l-
IL200192A (en) Use of l-cannitin and / or alkonial l-carnitine, or their common pharmaceutical salt, in combination with statin, for the preparation of a drug for the treatment of type 2 diabetes
HU0600409D0 (en) Izatin and it's derivatives for use as a medicine
EP2047851A4 (fr) Formulation médicamenteuse contenant un médicament fibrate et procédé pour la produire

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190606